ANDROBIOSYS
AndroBioSys, Inc. (ABS), is a biotechnology company dedicated to the development of novel treatments for prostate disease. Based on technologies developed at Roswell Park Cancer Institute, AndroBioSys is pioneering new approaches to make treatment of prostate cancer curative, not palliative. Preventing progression of prostate disease is intertwined intimately with disruption of the androgen axis. ABS performs contract research screening services for academic, biotechnology and pharmaceutical clients and develops collaborative partnerships to discover new drugs to proprietary prostate disease targets.
ANDROBIOSYS
Industry:
Biotechnology Health Care Life Science Therapeutics
Founded:
2005-01-01
Address:
New York, New York, United States
Country:
United States
Website Url:
http://www.androbiosys.com
Total Employee:
1+
Status:
Active
Contact:
7168453300
Total Funding:
500 K USD
Technology used in webpage:
U.S. Server Location
Similar Organizations
Avogadro Development Corp
A clinical-stage biotechnology company focused on pattern recognition receptors in immunometabolic disease.
Nativis
Nativis is a biotechnology company that focuses on the development of therapeutic modalities for the treatment of serious disease.
Orpheus Bioscience
Orpheus Bioscience is a privately-held biotech company that develops novel treatments for autoimmune diseases.
Ribonomics
Ribonomics is a systems biology company focused on the development of innovative products for the diagnosis.
Vigil Neuroscience
Vigil Neuroscience is a biotechnology company that develops novel therapeutics for neurodegenerative diseases.
Current Employees Featured
Founder
Investors List
Western New York Venture Association
Western New York Venture Association investment in Venture Round - AndroBioSys
Erie County Industrial Development Agency
Erie County Industrial Development Agency investment in Venture Round - AndroBioSys
Excell Partners
Excell Partners investment in Venture Round - AndroBioSys
Official Site Inspections
http://www.androbiosys.com
- Host name: aba1c1ff9d2ec5376.awsglobalaccelerator.com
- IP address: 76.223.26.96
- Location: Seattle United States
- Latitude: 47.54
- Longitude: -122.3032
- Metro Code: 819
- Timezone: America/Los_Angeles
- Postal: 98108
More informations about "AndroBioSys"
ANDROBIOSYS, INC. Company Profile | Buffalo, NY | Competitors ...
Find company research, competitor information, contact details & financial data for ANDROBIOSYS, INC. of Buffalo, NY. Get the latest business insights from Dun & Bradstreet.See details»
AndroBioSys - Funding, Financials, Valuation & Investors
AndroBioSys is a biotechnology company that focuses on the development of novel treatments for prostate disease. Search Crunchbase. Start Free Trial . Chrome Extension. ... How much …See details»
Androbiosys, Inc. - Company Profile - Corporation Wiki
Mar 19, 2024 Androbiosys, Inc. Overview. Androbiosys, Inc. filed as a Foreign Business Corporation in the State of New York on Wednesday, February 28, 2007 and is approximately …See details»
AndroBioSys - Contacts, Employees, Board Members, Advisors
AndroBioSys is a biotechnology company that focuses on the development of novel treatments for prostate disease. New. Resources. Advanced Search. Start Free Trial . Talk With Sales. …See details»
AndroBioSys - Company Profile - Tracxn
Feb 26, 2025 AndroBioSys is a biotechnology company engaged in the development of platelet-based nanoparticle therapy for prostate cancer. Offers AngioGraft Assay to evaluate …See details»
AndroBioSys - Tech Stack, Apps, Patents & Trademarks - Crunchbase
AndroBioSys is a biotechnology company that focuses on the development of novel treatments for prostate disease.See details»
Androbiosys Company Profile -Sales, Contacts, Competitors – …
Androbiosys is in the Biotechnical Research, Commercial industry within the Engineering, Accounting, Research, and Management Services sector and has been in business for …See details»
AndroBioSys, Inc.:Company Profile & Technical …
AndroBioSys is a company that provides Prostate disease, Biology, Health care and more. AndroBioSys is headquartered in United States New York. AndroBioSys was founded in 2005. …See details»
AndroBioSys, Inc.: Drug pipelines, Patents, Clinical trials - Synapse
Aug 30, 2023 Explore AndroBioSys, Inc. with its drug pipeline, therapeutic area, technology platform, .See details»
ANDROBIOSYS, INC. - VentureRadar
Find out more about ANDROBIOSYS, INC. including the VentureRadar Innovation and Growth scores, Similar Companies and more. All; Ranked; Organisation Names; Apps and Links. …See details»
AndroBioSys - Products, Competitors, Financials, Employees ...
AndroBioSys (ABS) is a biotech company focused on developing more effective treatments for prostate disease. Use the CB Insights Platform to explore AndroBioSys's full profile.See details»
AndroBioSys Inc.
Mar 1, 2009 AndroBioSys is pursuing a dual strategy for treating prostate disease: it's running a contract research business while it builds a therapeutic pipeline. One of the company's …See details»
ANDROBIOSYS, INC. | SBIR.gov
DESCRIPTION (provided by applicant): AndroBioSys, Inc. is dedicated to the development of human tissue-based in vivo tools capable of selecting better targeted agents for clinical trials …See details»
Androbiosys Inc - Company Profile and News - Bloomberg Markets
Androbiosys, Inc. was founded in 2005. The company's line of business includes providing commercial physical and biological research and development. ...See details»
AndroBioSys - Raised $700K Funding from 8 investors - Tracxn
Feb 26, 2025 AndroBioSys has raised a total funding of $700K over 4 rounds from 8 investors. Investors include Defense.gov, SBIR and 6 others. Their latest funding round was of $2M on …See details»
AndroBioSys - Crunchbase
AndroBioSys is a biotechnology company that focuses on the development of novel treatments for prostate disease.See details»
AndroBioSys | IT History Society
AndroBioSys is a biotechnology company that focuses on the development of novel treatments for prostate disease.AndroBioSys, Inc. (ABS), is a biotechnology company dedicated to the …See details»
Annual Report on AndroBioSys's Revenue, Growth, SWOT Analysis ...
Determine whether AndroBioSys grew or shrank during the last recession. This is useful in estimating the financial strength and credit risk of the company. Compare how recession-proof …See details»
AndroBioSys Licenses Technology from Roswell Park Cancer …
Aug 2, 2007 AndroBioSys will focus its efforts on identifying specific targets in prostate tumors (e.g., prostate vasculature, tumor stem cells, and androgen metabolism), which may be …See details»